在HER2阴性早期乳腺癌患者的特征,治疗模式和临床结果
Jay A Andersen1, Jagadeswara Rao Earla2, Nicole Fulcher3
1Medical Oncology and Hematology, Compass Oncology, Tigard, OR, USA.
Future oncology (London, England)
|August 22, 2025
概括
在HER2-早期乳腺癌患者中,生殖系BRCA (gBRCA) 突变状态没有显著改变存活率. 然而,gBRCA突变状态显示出轻微的生存劣势,强调了改进的基因测试文档需求.
科学领域:
- 癌症学
- 遗传学
- 临床研究
背景情况:
- 在HER2-早期乳腺癌 (eBC) 治疗和生存率各不相同.
- 生殖线BRCA (gBRCA) 突变影响治疗决策和结果.
研究的目的:
- 在接受全身治疗的HER2- eBC患者中评估治疗模式和生存率.
- 为了比较gBRCA突变 (gBRCAm) 和野生型 (gBRCAwt) 患者的结果.
主要方法:
- 追溯观察队列研究.
- 对gBRCA检测率,治疗模式和生存数据的分析.
- gBRCAm和gBRCAwt群体之间的比较.
主要成果:
- 在受试患者中,gBRCA测试率为8. 2%,突变率为9. 8%.
- 根据激素受体和HER2状态,治疗模式有所不同.
- 根据gBRCA状态,生存结果没有显著差异,gBRCAm患者的生存趋势较差.
结论:
- 在 HER2- eBC 中,gBRCA 突变状态没有显著影响生存率.
- 观察到的测试和突变率凸显了电子健康记录的不足.
- 需要在现实环境中更好地获取基因测试数据.
更多相关视频
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
12.7K
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
12.3K
相关概念视频
01:21Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K